» Articles » PMID: 17163796

The Congenital Muscular Dystrophies: Recent Advances and Molecular Insights

Overview
Date 2006 Dec 14
PMID 17163796
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past decade, molecular understanding of the congenital muscular dystrophies (CMDs) has greatly expanded. The diseases can be classified into 3 major groups based on the affected genes and the location of their expressed protein: abnormalities of extracellular matrix proteins (LAMA2, COL6A1, COL6A2, COL6A3), abnormalities of membrane receptors for the extracellular matrix (fukutin, POMGnT1, POMT1, POMT2, FKRP, LARGE, and ITGA7), and abnormal endoplasmic reticulum protein (SEPN1). The diseases begin in the perinatal period or shortly thereafter. A specific diagnosis can be challenging because the muscle pathology is usually not distinctive. Immunostaining of muscle using a battery of antibodies can help define a disorder that will need confirmation by gene testing. In muscle diseases with overlapping pathological features, such as CMD, careful attention to the clinical clues (e.g., family history, central nervous system features) can help guide the battery of immunostains necessary to target an unequivocal diagnosis.

Citing Articles

Exploring Splice-Site Mutations in LAMA2-Related Muscular Dystrophies: A Comprehensive Analysis of Genotypic and Phenotypic Patterns.

Nmer S, Ameli A, Trhanint S, Chaouki S, Bouguenouch L, Ouldim K Cureus. 2024; 16(6):e61599.

PMID: 38962616 PMC: 11221619. DOI: 10.7759/cureus.61599.


Association between Decreased ITGA7 Levels and Increased Muscle α-Synuclein in an MPTP-Induced Mouse Model of Parkinson's Disease.

Han S, Lim S, Yeo S Int J Mol Sci. 2022; 23(10).

PMID: 35628462 PMC: 9143933. DOI: 10.3390/ijms23105646.


Laminin Polymerization and Inherited Disease: Lessons From Genetics.

Shaw L, Sugden C, Hamill K Front Genet. 2021; 12:707087.

PMID: 34456976 PMC: 8388930. DOI: 10.3389/fgene.2021.707087.


Identifying Common Genes, Cell Types and Brain Regions Between Diseases of the Nervous System.

Qi M, Fan S, Wang Z, Yang X, Xie Z, Chen K Front Genet. 2019; 10:1202.

PMID: 31850066 PMC: 6895906. DOI: 10.3389/fgene.2019.01202.


Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic.

Canassa-DeLeo T, Campo V, Rodrigues L, Marchiori M, Fuzo C, Brigido M Glycoconj J. 2019; 37(1):77-93.

PMID: 31823246 DOI: 10.1007/s10719-019-09893-z.


References
1.
Coral-Vazquez R, Rosas-Vargas H, Meza-Espinosa P, Mendoza I, Huicochea J, Ramon G . Severe congenital muscular dystrophy in a Mexican family with a new nonsense mutation (R2578X) in the laminin alpha-2 gene. J Hum Genet. 2003; 48(2):91-5. DOI: 10.1007/s100380300013. View

2.
Guo L, Zhang X, Kuang W, Xu H, Liu L, Vilquin J . Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice. Neuromuscul Disord. 2003; 13(3):207-15. DOI: 10.1016/s0960-8966(02)00266-3. View

3.
Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D . FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology. 2003; 60(6):988-92. DOI: 10.1212/01.wnl.0000052996.14099.dc. View

4.
Di Muzio A, De Angelis M, Di Fulvio P, Ratti A, Pizzuti A, Stuppia L . Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Muscle Nerve. 2003; 27(4):500-6. DOI: 10.1002/mus.10326. View

5.
Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R . Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol. 2003; 53(4):537-42. DOI: 10.1002/ana.10559. View